Home » Topics » Regulatory » Patents

Patents
RSS

RespiVert prepares novel MAP kinase p38 inhibitors

Nov. 4, 2011

New mTOR inhibitors disclosed by Auspex Pharmaceuticals

Nov. 4, 2011

Novel receptor-interacting protein 2 inhibitors prepared by GSK

Nov. 3, 2011

Array BioPharma and Genentech jointly synthesize new beta-secretase 1 inhibitors

Nov. 3, 2011

Novel histone deacetylase inhibitors disclosed

Nov. 3, 2011

OncoTherapy Science patents novel PDZ-binding kinase inhibitors

Nov. 3, 2011

Scientists at Amgen disclose new PI3K inhibitors

Nov. 3, 2011

Takeda Pharmaceutical prepares novel histamine H3 receptor antagonists

Nov. 2, 2011

Piramal Life Sciences synthesizes new cytokine inhibitors

Nov. 2, 2011

Sanofi presents new Met inhibitors

Nov. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...